1,4-Anhydro-1,5-dihydroxy-3-epi-Empagliflozin D4
| Product Name | 1,4-Anhydro-1,5-dihydroxy-3-epi-Empagliflozin D4 |
|---|---|
| Alternate Names | Empagliflozin Stable Isotopes, Stable Isotopes of Empagliflozin |
| CAT No. | CS-O-12065 |
| CAS No. | Not Available |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Empagliflozin |
| Therapeutic | Anti-Diabetic |
| Smileys | ClC1=CC=C(C=C1CC2=C(C([2H])=C(C([2H])=C2[2H])O[C@H]3CCOC3)[2H])C4O[C@@H]([C@@H](CO)O)[C@H](O)[C@H]4O |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
1,4-Anhydro-1,5-dihydroxy-3-epi-Empagliflozin D4 is a deuterated form of Empagliflozin, a medication that is used to treat type 2 diabetes. Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, which works by preventing the kidneys from reabsorbing glucose and allowing excess glucose to be excreted in the urine. This reduces blood glucose levels and improves glycemic control in patients with type 2 diabetes.
1,4-Anhydro-1,5-dihydroxy-3-epi-Empagliflozin D4 is a labeled form of Empagliflozin that is used in pharmacokinetic studies to determine the metabolism and distribution of the drug in the body. The deuterium label allows researchers to track the drug and its metabolites using mass spectrometry, which provides valuable information on how the drug is absorbed, distributed, metabolized, and eliminated from the body.
Chemically, 1,4-Anhydro-1,5-dihydroxy-3-epi-Empagliflozin D4 has a molecular formula of C23H23D4ClO7 and a molecular weight of 486.96 g/mol. It is a white to off-white powder that is soluble in water and has a melting point of 194-198°C. The drug is typically administered orally in tablet form, with a recommended dose of 10 mg once daily for the treatment of type 2 diabetes. However, the dosage may vary depending on the patient's condition and response to the medication.
Get an Instant Quote
Related Compounds
Empagliflozin D6 | Empagliflozin D8 | Empagliflozin 13C6 | Empagliflozin 13C6 | Empagliflozin D4 |